Anuh Pharma Limited

Rachunek Zysków i Strat





Przychody TTM (mln): 6 399
EBIT TTM (mln): 760
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Rok finansowy 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025
Przychód (mln) 818 1,109 1,205 1,646 1,755 2,257 2,427 2,664 2,837 3,262 2,061 2,381 3,207 3,070 4,320 4,866 5,275 6,470 6,615
Przychód Δ r/r 0.0% 35.6% 8.7% 36.6% 6.7% 28.6% 7.5% 9.8% 6.5% 15.0% -36.8% 15.5% 34.7% -4.3% 40.7% 12.7% 8.4% 22.7% 2.2%
Marża brutto 17.0% 13.7% 15.7% 10.1% 15.9% 16.4% 17.5% 19.6% 21.9% 23.8% 26.9% 24.1% 24.2% 25.0% 23.7% 22.4% 23.9% 20.5% 24.5%
EBIT (mln) 106 117 141 176 -1,614 171 176 242 296 324 214 197 335 239 310 378 450 666 522
EBIT Δ r/r 0.0% 10.4% 20.9% 25.3% -1014.4% -110.6% 3.0% 37.1% 22.5% 9.3% -33.9% -8.0% 70.3% -28.8% 29.9% 21.9% 19.3% 47.8% -21.6%
EBIT (%) 12.9% 10.5% 11.7% 10.7% -91.9% 7.6% 7.3% 9.1% 10.4% 9.9% 10.4% 8.3% 10.5% 7.8% 7.2% 7.8% 8.5% 10.3% 7.9%
Koszty finansowe (mln) 1 2 8 1 1 1 0 1 0 0 0 0 2 8 15 10 2 4 6
EBITDA (mln) 118 127 152 188 -1,603 185 193 259 329 401 267 249 328 295 475 493 530 751 704
EBITDA(%) 14.4% 11.5% 12.6% 11.4% -91.3% 8.2% 8.0% 9.7% 11.6% 12.3% 13.0% 10.5% 10.2% 9.6% 11.0% 10.1% 10.1% 11.6% 10.6%
Podatek (mln) 36 37 46 50 52 52 51 79 99 121 75 69 90 49 101 86 113 183 137
Zysk Netto (mln) 69 78 87 125 123 128 125 176 220 258 201 165 234 143 284 306 362 601 474
Zysk netto Δ r/r 0.0% 13.0% 12.0% 43.9% -2.0% 4.5% -2.4% 40.3% 25.0% 17.3% -22.3% -17.6% 41.5% -38.8% 98.8% 7.5% 18.4% 66.0% -21.2%
Zysk netto (%) 8.4% 7.0% 7.2% 7.6% 7.0% 5.7% 5.2% 6.6% 7.8% 7.9% 9.7% 6.9% 7.3% 4.7% 6.6% 6.3% 6.9% 9.3% 7.2%
EPS 1.37 1.55 1.74 2.5 2.45 2.56 2.5 3.51 4.39 5.15 4.0 3.3 4.66 2.85 5.67 6.1 7.22 11.98 9.45
EPS (rozwodnione) 1.37 1.55 1.74 2.5 2.45 2.56 2.5 3.51 4.39 5.15 4.0 3.3 4.66 2.85 5.67 6.1 7.22 11.98 9.45
Ilośc akcji (mln) 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50
Ważona ilośc akcji (mln) 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50
Waluta INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR INR